↧
Biotech Trends Update — Biosimilars: FDA Meeting in November to Discuss BCPI...
Adam Feuerstein at TheStreet.com reported this morning on a draft FDA notice for a planned November meeting on implementation of the Biologics Price Competition and Innovation Act, which was passed as...
View ArticleBiotech Trends in 2011: Biosimilars
In our original post on biosimilars, Lumira Capital’s Beni Rovinski set out the business opportunities, the technical challenges and the regulatory hurdles facing follow-on biologics in 2009. Since...
View Article